Home › BioCryst Pharmaceuticals Price Target Lowered to $10.00 at Jefferies Group
 

Keywords :   


BioCryst Pharmaceuticals Price Target Lowered to $10.00 at Jefferies Group

2015-10-18 09:44:56| Biotech - Topix.net

The firm presently has a "hold" rating on the biotechnology company's stock. Jefferies Group's price objective would indicate a potential upside of 13.12% from the stock's previous close.

Tags: price group target lowered

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
06.10Hurricane Leslie Wind Speed Probabilities Number 15
06.10Hurricane Leslie Public Advisory Number 15
06.10Summary for Hurricane Leslie (AT3/AL132024)
06.10Hurricane Leslie Forecast Advisory Number 15
06.10Hurricane Kirk Forecast Discussion Number 27
More »